News and Events
News From Inside
FyoniBio collaborates with BioLamina and Alder Therapeutics
FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications.
FyoniBio gets CIR accreditation
We are pleased to announce that FyoniBio has received CIR (Crédit d’Impôt Recherche or CIR) accreditation for three years until 2025, which will benefit our French clientele.
Launch of FyoniBio’s CHOFlow® Technology
CHOFlow®: Our high yield expression technology for afucosylated ADCC enhanced antibodies and beyond.
Successful Cell Line Development for Strike Pharma
Strike Pharma and FyoniBio Conclude Successfully Cell Line Development of Strike’s Bi-specific Antibody and Clinical Lead Candidate.
Service Agreement with adivo
FyoniBio and adivo GmbH sign a Service Agreement covering the generation of a production cell line for their canine therapeutic mAb candidate
Cooperation with Strike Pharma
We have signed a Master Service Agreement with Strike Pharma covering the cell line development for a novel bi-specific therapeutic mAb.
Partnership with ProteoNic
We have signed a license agreement for using ProteoNic’s 2G Unic™ technology in our cell line development platform.
Launch of FyoniBio GmbH
The FyoniBio service branch of Glycotope GmbH will continue its business as FyoniBio GmbH.
Cooperation with BioGenes
BioGenes and FyoniBio begin a cooperation for Pharmacokinetic & Immunogenicity Analyses
Collaboration with CSL Behring
We are happy to have initiated a collaboration with CSL Behring research division.
Current and Upcoming Events
TIDES Europe 2024
FyoniBio is excited to participate in TIDES Europe – the top industry event, featuring the latest data and insights from globally recognized speakers and companies! Let’s discover innovations across oligonucleotides, peptides, mRNA, drug delivery, and partnerships from early discovery to market entry together.
12–14 November 2024
PEGS Europe 2024
Connect with FyoniBio at the 16th Annual PEGS Europe in Barcelona, Spain! This event is essential for advancing biologics development, gathering leading experts in biologics innovation. Explore the latest technologies, cutting-edge research, and breakthroughs in drug development, protein and antibody engineering, immunotherapy, expression platforms, multispecific antibodies, and the integration of machine learning and AI in biologics.
5–7 November 2024
COG Europe 2024
Join the Clinical Outsourcing Group Europe Meeting—the leading event for clinical-stage biopharma executives across Europe. Bringing together industry experts, regulatory authorities, and academic leaders, COG Europe offers two days of dynamic networking, insightful discussions, and thought leadership. With interactive content sessions, attendees will gain valuable insights and practical takeaways to drive their projects forward.
12–13 November 2024